News | Cardiovascular Ultrasound | June 27, 2019

FDA Issues Final Guidance on Marketing Clearance of Diagnostic Ultrasound Systems and Transducers

New guidance includes needed information for 510(k) submissions, modifications not requiring new submissions and new transducer element integrity check

FDA Issues Final Guidance on Marketing Clearance of Diagnostic Ultrasound Systems and Transducers

June 26, 2019 — The U.S. Food and Drug Administration (FDA) issued the final guidance: Marketing Clearance of Diagnostic Ultrasound Systems and Transducers. This final guidance provides detailed recommendations for manufacturers seeking marketing clearance of diagnostic ultrasound systems and transducers.

This final guidance:

  • Provides recommendations on information that should be included in a premarket notification (510(k) submission) for diagnostic ultrasound systems and transducers;
  • Describes the types of modifications to a diagnostic ultrasound device for which the FDA does not intend to enforce the requirement to submit a new premarket notification (510(k) submission); and
  • Introduces a new transducer element integrity check which applies to all the ultrasound devices covered in the guidance.

On Aug. 22, 2019, the FDA will host a webinar  for device manufacturers and others interested in learning more about this final guidance.

Read the full guidance document here.

For more information: www.fda.gov

Related Content

EchoGo Pro automates cardiac ultrasound measurements for heart functions, but also empower physicians to predict the occurrence of coronary artery disease (CAD).

EchoGo Pro automates cardiac ultrasound measurements for heart functions, but also empower physicians to predict the occurrence of coronary artery disease (CAD).

News | Cardiovascular Ultrasound | September 25, 2020
September 25, 2020 — Based on its recent analysis of the global...
The Epiq CVxi being used for TEE imaging in the cath lab. The system brings together advanced image quality, quantification and intelligence specifically for the cardiologist.

The Epiq CVxi being used for TEE imaging in the cath lab. The system brings together advanced image quality, quantification and intelligence specifically for the cardiologist.

News | Cardiovascular Ultrasound | September 15, 2020
September 15, 2020 — Philips Healthcare recently introduced the latest addition to its portfolio of dedicated...
GE Healthcare Vscan with artificial intelligence (AI) automated left ventricular ejection fraction assessment with the Dia LVivo EF app. #ASE2020

GE Healthcare Vscan with artificial intelligence (AI) automated left ventricular ejection fraction assessment with the Dia LVivo EF app.

News | Cardiovascular Ultrasound | August 12, 2020
August 12, 2020 — GE focused on the latest innovations from the handheld ultrasound,...
TomTec offers innovations in cardiac ultrasound, including AI and auto quanitification of echo images.

TomTec offers innovations in cardiac ultrasound, including AI and auto quanitification of echo images.

News | Cardiovascular Ultrasound | August 04, 2020
August 4, 2020 — Imaging software company TomTec has released its new TomTec-Arena 2020 product, which offers new adv
Judy Hung, M.D., speaking with DAIC Editor Dave Fornell during a video interview at the 2019 American Society of Echocardiography (ASE) annual meeting. Hung took over as ASE President in June.

Judy Hung, M.D., speaking with DAIC Editor Dave Fornell during a video interview at the 2019 American Society of Echocardiography (ASE) annual meeting. Hung took over as ASE President in June.

News | Cardiovascular Ultrasound | July 09, 2020
July 8, 2020 – Judy W.
A Philips Healthcare transesophageal echocardiography (TEE) system in use in a hybrid OR.

A Philips Healthcare transesophageal echocardiography (TEE) system in use in a hybrid OR.

News | Cardiovascular Ultrasound | June 04, 2020
June 4, 2020 — Intra-operative...